Mass. Governor Deval Patrick was on hand today for the completion of Organogenesis Inc.’s new headquarters in Canton.
The regenerative medicine developer is in the midst of an expansion that includes the new headquarters, R&D and manufacturing facilities. The company received a $7.4 million grant to help facilitate the growth from the Mass. Life Sciences Center, funded by Patrick’s Life Sciences Initiative.
“We are pleased to see Organogenesis’ rapid growth after their decision to expand here in the Commonwealth. The regenerative medicine industry was born here, in our state’s universities and labs. We are proud of the innovative and advanced technologies invented in Massachusetts, and it’s very rewarding to see the industry taking shape and creating new jobs in our state,” Patrick said in prepared remarks.
Organogenesis capped the grip-and-grin event with news that it would be hiring new employees and participating in the Bay State’s “Stay Here” initiative, a program designed to keep recent college grads in the Commonwealth.
Organogenesis also landed approval for its Apligraf treatment for diabetic foot ulcers in Saudi Arabia, the company announced today at the event.
Also, today, Lt. Gov. Tim Murray announced the Life Sciences Center’s new endeavor to help vocational technical schools, community colleges and workforce training organizations build out their laboratory facilities.
The so-called Equipment and Supplies Program for Skills Training and Education will match industry partner funding for the purchase of lab equipment at the institutions. The Center will begin accepting applications for the program Oct. 4 on its website.
"One of the most common concerns that I hear from leaders in the life sciences industry is the need for skilled workers, such as lab technicians and individuals with training in biomanufacturing," MLSC CEO Susan Windham-Bannister said in prepared remarks (PDF).